Technical analysis of ENDRA Life Sciences Inc. (NDRA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood.
Price Performance
| 1 month | +17.52% |
| 3 months | +11.34% |
| Year-to-date | +17.00% |
| 1 year | +12.53% |
| 3 years | -99.75% |
| 5 years | -99.99% |
52-Week Range
| 52-week High | $9.85 |
| 52-week Low | $2.96 |
| Avg Volume (90d) | 36K |
Technical Indicators
| SMA 50 | $5.04 |
| SMA 200 | $4.76 |
| 30-day Volatility (annualised) | 94.2% |
| Price vs SMA 50 | +5.1% |
| Price vs SMA 200 | +11.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $5.25 | |
| 2025-11 | $5.91 | +12.6% |
| 2025-12 | $4.53 | -23.4% |
| 2026-01 | $3.80 | -16.1% |
| 2026-02 | $4.15 | +9.2% |
| 2026-03 | $4.65 | +12.0% |
| 2026-04 | $4.87 | +4.7% |
| 2026-05 | $5.50 | +12.9% |
| 2026-06 | $5.33 | -3.1% |
| 2026-07 | $4.70 | -11.8% |
| 2026-08 | $5.01 | +6.6% |
| 2026-09 | $5.30 | +5.8% |
Price
| Price | $5.30 |
| Market Cap | $7M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.11 |
| EV / EBITDA | -0.48 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.07 |
| Current Ratio | 7.10 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -43.65 |